12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Kineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Orgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday’s after-market session. The company’s market cap stands…
ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Nasdaq Edges Lower; ContextLogic Shares Surge
U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday.
The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The S&P 500 also rose, gaining, 0.12% to 5,032.46.
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results.
Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Renalytix (NASDAQ:RNLX) stock rose 490.4% to $2.25 during Monday’s regular session. The market value of their outstanding…
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday.
The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87.
US Stocks Mixed; Trimble Issues Weak Outlook
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday.
Following the market opening Monday, the Dow traded down 0.05% to 38,651.80 while the NASDAQ rose 0.09% to 16,004.39. The S&P 500 also rose, gaining, 0.01% to 5,026.74.
Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today?
AN2 Therapeutics pauses Phase 3 enrollment for epetraborole trial in Mycobacterium Avium Complex lung disease. Updates expected in summer 2024.
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday.
Shares of monday.com Ltd. (NASDAQ: MNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results.